Alaska Newborn Screening Program
Phone: 907-334-2295
Fax: 907-754-3455
Email: newborn.screening@alaska.gov
Alaska Newborn Screening Program Website
Total number of conditions screened in this state: 54
2-methyl-3-hydroxybutyric acidemia2-methylbutyrylglycinuria
3-hydroxy 3-methyglutaric aciduria
3-methylcrotonyl-CoA carboxylase
3-methylglutaconic aciduria
Argininemia
Argininosuccinic aciduria
Benign hyperphenylalaninemia
Biotinidase deficiency
Carnitine acylcarnitine translocase
Carnitine palmitoyltransferase type I
Carnitine palmitoyltransferase type II
Carnitine uptake defect (carnitine transport defect)
Citrullinemia, type 1 or ASA synthetase deficiency
Citrullinemia, type II
Classic galactosemia
Classic phenylketonuria
Congenital adrenal hyperplasia
CPT1A Arctic Variant
Critical congenital heart disease
Cystic fibrosis
Defects of biopterin cofactor biosynthesis
Defects of biopterin cofactor regeneration
Glutaric acidemia type I
Glutaric acidemia type II
Hearing loss
Holocarboxylase synthase
Homocystinuria (cystathionine beta synthetase)
Hypermethioninemia
Isovaleric acidemia
Long-chain L-3 hydroxyacyl-CoA dehydrogenase
Malonic acidemia
Maple syrup urine disease
Medium chain acyl-CoA dehydrogenase
Medium-chain ketoacyl-CoA thiolase
Medium/short chain L-3-hydroxyacyl-CoA dehydrogenase
Methylmalonic acidemia (cobalamin disorders, vitamin B12 disorders)
Methylmalonic acidemia (methylmalonyl-CoA mutase)
Methylmalonic acidemia with homocystinuria
Primary congenital hypothyroidism
Propionic acidemia
S, βeta-thalassemia
S,C disease
S,S disease (sickle cell anemia)
Severe combined immunodeficiency
Short-chain acyl-CoA dehydrogenase deficiency
Spinal muscular atrophy
Trifunctional protein deficiency
Tyrosinemia, type I
Tyrosinemia, type II
Tyrosinemia, type III
Variant hemoglobinopathies
Very long-chain acyl-CoA dehydrogenase
βeta-ketothiolase
Last Reviewed 12/01/2023